Clene Nanomedicine
About:
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
Website: https://clene.com/
Twitter/X: clenenano
Top Investors: National Institutes of Health, National Multiple Sclerosis Society (NMSS), FightMND, Maryland Department of Housing and Community Development, SymBiosis LLC
Description:
Clene Nanomedicine is a clinical-stage biopharmaceutical company that focuses on the development of unique therapeutics for neurodegenerative diseases. The company innovated a novel nanotechnology drug platform for the development of a new class of orally-administered neurotherapeutic drugs.
$190M
$1M to $10M
Salt Lake City, Utah, United States
2013-01-01
info(AT)clenenanomedicine.com
Mark Mortenson
51-100
2024-09-30
Public
© 2025 bioDAO.ai